July 23, 2025Communications BiologyOpen Access

Adipose-derived mesenchymal stromal/stem cells in type 1 diabetes treatment

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Review highlights immunomodulatory effects and insulin independence in type 1 diabetes using stem cells, suggesting further research is needed.

Adipose-derived mesenchymal stromal/stem cells offer a promising treatment for type 1 diabetes.
Research shows that these cells reduce insulin dependence and boost β cell mass in models.
Challenges like quality control and functional variability limit widespread use of ADMSC therapies.
Current findings suggest significant potential, emphasizing the need for standardized approaches in treatment.

Sood et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Review highlights immunomodulatory effects and insulin independence in type 1 diabetes using stem cells, suggesting further research is needed.